Algeria's Ministry of Health has signed a cooperation agreement with Boehringer Ingelheim Algeria to support efforts in caring for stroke and rare diseases. The agreement was signed by Health Minister Professor Mohamed Seddik Ait Masoudan and Boehringer Ingelheim's Regional General Manager for IMETA, Derek O'Leary. The partnership aims to improve public health through evidence-based approaches, assessing available resources and prioritizing needs.
The agreement was signed by Director of Treatment Programs and Medical Ethics, Souheila Lellou, on behalf of the Ministry of Health, and Boehringer Ingelheim Algeria's Manager, Samir Lahmaki. This collaboration focuses on enhancing cooperation and partnership in public health, adopting an evidence-based approach to evaluate available resources and identify priority needs. The agreement also aims to establish mechanisms to improve patient care.
The partnership includes supporting and strengthening the capabilities of healthcare professionals, as well as accompanying efforts to digitize the stroke care system. This will contribute to improving care pathways, enhancing coordination among various stakeholders, and elevating the quality of healthcare services provided to patients. The Ministry of Health is working to develop care pathways for priority diseases.
The agreement is part of the Ministry of Health's efforts to develop care pathways for priority diseases, enhance prevention, early diagnosis, and comprehensive care. This approach responds to patient needs and supports improving the performance of the national healthcare system. The partnership with Boehringer Ingelheim Algeria is a significant step towards achieving these goals.
The cooperation agreement between the Ministry of Health and Boehringer Ingelheim Algeria reflects the government's commitment to improving healthcare services. By working together, the two parties aim to address the challenges faced by the healthcare system and provide better care for patients with stroke and rare diseases. The partnership will focus on implementing effective solutions.
The partnership will also focus on supporting the Ministry of Health's efforts to enhance the quality of healthcare services. By leveraging Boehringer Ingelheim's expertise and resources, the Ministry aims to improve patient outcomes and enhance the overall performance of the healthcare system. The agreement is expected to have a positive impact on the lives of patients.
The Ministry of Health's efforts to enhance stroke and rare disease care are part of a broader strategy to improve the healthcare system. The partnership with Boehringer Ingelheim Algeria is a key component of this strategy, and the Ministry is committed to working with international partners to achieve its goals. The agreement marks a significant milestone in Algeria's healthcare sector.
Key points
- Algeria's Health Ministry partners with Boehringer Ingelheim to enhance stroke and rare disease care.
